Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Caicun Zhou, Jianjun Zou, Yiping Zhang et al.|The Lancet Respiratory Medicine|2020

Cited by 504